Webinar | April 18, 2019

CAR T Cell Therapy And Other Technologies Emerging In Oncology Research

CAR T cell therapy, or adoptive cell therapy, is a type of treatment in which a patient’s own T cells are manipulated in a lab by adding an artificial receptor, or a “CAR.” In conjunction with the patient’s own T cells, the CAR enables the final product to produce chemicals in the hopes that the “enhanced” product or cells will bind to the cancer cells and kill them.

Some of these unique therapies have already been approved by the US Food and Drug Administration (FDA) and are the first steps toward further groundbreaking science.

In this webinar, Emile Youssef, Premier Research’s Executive Medical Director, reviews the operational and clinical pathways that are helping to bring these technologies to patients.

VIEW THE WEBINAR!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: